









市場
/
株式
/
nasdaq-orgo
/

Organogenesis Holdings Inc

ORGO

4.575USD

+0.065+1.44%

取引時間（ET）15分遅れの株価

580.35M時価総額

損失額直近12ヶ月PER



Organogenesis Holdings Inc

4.575

+0.065+1.44%

概要企業名金融

Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Its advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier and native, cross-linked extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types. Sports Medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for management of open wounds in the surgical setting.

企業情報

企業コードORGO

会社名Organogenesis Holdings Inc

上場日Dec 02, 2016

最高経営責任者「CEO」Mr. Gary S. Gillheeney, Sr.

従業員数869

証券種類Ordinary Share

決算期末Dec 02

本社所在地85 Dan Rd

都市CANTON

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号02021-2810

電話番号17815750775

ウェブサイトhttps://investors.organogenesis.com

企業コードORGO

上場日Dec 02, 2016

最高経営責任者「CEO」Mr. Gary S. Gillheeney, Sr.

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Glenn H. Nussdorf

Director

11.91M

Mr. Patrick Bilbo

Chief Operating Officer

447.51K

-8.12%

Mrs. Lori Freedman, J.D.

Chief Administrative and Legal Officer

419.71K

+150.65%

Mr. Brian Grow

Chief Commercial Officer

200.53K

-20.89%

Mr. Robert Cavorsi

Vice President - Strategy

189.16K

-0.19%

Mr. Antonio S. Montecalvo

Vice President - Health Policy

188.20K

+17.78%

Mr. Arthur S. Leibowitz, CPA

Lead Independent Director

187.61K

+0.78%

Ms. Prathyusha Duraibabu, CPA

Independent Director

148.64K

+3.64%

Mr. Jon L. Giacomin

Independent Director

142.62K

+2.31%

Dr. Gilberto Quintero, Ph.D.

Independent Director

140.67K

+1.04%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Glenn H. Nussdorf

Director

11.91M

Mr. Patrick Bilbo

Chief Operating Officer

447.51K

-8.12%

Mrs. Lori Freedman, J.D.

Chief Administrative and Legal Officer

419.71K

+150.65%

Mr. Brian Grow

Chief Commercial Officer

200.53K

-20.89%

Mr. Robert Cavorsi

Vice President - Strategy

189.16K

-0.19%

Mr. Antonio S. Montecalvo

Vice President - Health Policy

188.20K

+17.78%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

事業別USD

会社名

収益

比率

Advanced Wound Care

79.93M

92.20%

Surgical & Sports Medicine

6.77M

7.80%

データなし

事業別

地域別

事業別USD

会社名

収益

比率

Advanced Wound Care

79.93M

92.20%

Surgical & Sports Medicine

6.77M

7.80%

株主

更新時刻: Sat, Jul 12

株主統計

種類

株主統計

比率

Soleus Capital Management, L.P.

9.84%

Morgan Stanley & Co. LLC

9.49%

Nussdorf (Glenn H)

9.39%

Ades (Alan A)

8.82%

Erani (Dennis)

7.92%

Other

54.55%

株主統計

比率

Soleus Capital Management, L.P.

9.84%

Morgan Stanley & Co. LLC

9.49%

Nussdorf (Glenn H)

9.39%

Ades (Alan A)

8.82%

Erani (Dennis)

7.92%

Other

54.55%

種類

株主統計

比率

Individual Investor

32.52%

Investment Advisor

16.60%

Corporation

14.12%

Investment Advisor/Hedge Fund

13.05%

Hedge Fund

12.78%

Research Firm

10.83%

Sovereign Wealth Fund

0.38%

Pension Fund

0.36%

Bank and Trust

0.06%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

301

127.82M

100.77%

+5.72M

2025Q1

324

125.21M

99.06%

+1.00M

2024Q4

344

121.01M

95.72%

-4.65M

2024Q3

354

109.09M

82.30%

-7.23M

2024Q2

369

107.79M

81.32%

-6.45M

2024Q1

374

102.47M

77.65%

-12.90M

2023Q4

378

102.14M

77.80%

-10.89M

2023Q3

390

113.75M

86.92%

-11.36M

2023Q2

400

112.98M

86.34%

-14.25M

2023Q1

400

117.68M

90.49%

-17.51M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Soleus Capital Management, L.P.

12.48M

9.84%

-6.53K

-0.05%

Mar 31, 2025

Morgan Stanley & Co. LLC

12.03M

9.49%

+286.33K

+2.44%

Mar 31, 2025

Nussdorf (Glenn H)

11.91M

9.39%

Jun 24, 2025

Ades (Alan A)

11.19M

8.82%

Jun 24, 2025

Erani (Dennis)

10.04M

7.92%

Jun 24, 2025

Organo PFG LLC

8.28M

6.53%

Jun 24, 2025

RED Holdings, L.L.C.

6.78M

5.35%

Jun 24, 2025

BlackRock Institutional Trust Company, N.A.

4.54M

3.58%

-205.40K

-4.33%

Mar 31, 2025

The Vanguard Group, Inc.

4.43M

3.49%

+841.62K

+23.44%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

3.10M

2.44%

+311.13K

+11.15%

Mar 31, 2025

詳細を見る